Level of virulent virus excreted by infected pigs previously vaccinated with different glycoprotein deleted Aujeszky's disease vaccines
- PMID: 1663287
- DOI: 10.1016/0378-1135(91)90129-4
Level of virulent virus excreted by infected pigs previously vaccinated with different glycoprotein deleted Aujeszky's disease vaccines
Abstract
Seven deleted Aujeszky's disease vaccines were compared for their ability to induce an immunity which suppresses virus excretion. For each vaccine, the levels of clinical protection and viral excretion were compared. Groups of eight pigs were vaccinated twice with attenuated deleted Aujeszky's disease vaccines (which do not express certain glycoproteins: gI, gX or gp63). Pigs were vaccinated at the beginning of the fattening period and challenge took place at the end of it when the pigs were 18-19 weeks old. Live virus vaccines were suspended in water or in an oil-in-water emulsion. The experiment was performed in three successive assays of two groups of eight pigs (except three groups for the first assay). At each assay, a control unvaccinated group of eight pigs was added to compare the effects of challenge between vaccinated and unvaccinated animals. In total, 80 pigs were involved in this experiment. All the vaccinated pigs excreted virus from 3 to 9 d after challenge. However the level of viral excretion and the duration of the period of excretion were reduced after vaccination and especially, when oil-in-water emulsion was used. There were obvious differences between vaccines. With some vaccines, when the level of viral excretion was low, the level of clinical protection was high. However, in other cases, the level of clinical protection could be good despite a higher level of viral excretion. The seroneutralizing titres were significantly and inversely related to a low level of viral excretion but not to the level of clinical protection.
Similar articles
-
Extent and duration of virulent virus excretion upon challenge of pigs vaccinated with different glycoprotein-deleted Aujeszky's disease vaccines.Vet Microbiol. 1990 Apr;22(2-3):107-17. doi: 10.1016/0378-1135(90)90098-g. Vet Microbiol. 1990. PMID: 2162094
-
Efficacy of an intranasal immunization with gEgC and gEgI double-deletion mutants of Aujeszky's disease virus in maternally immune pigs and the effects of a successive intramuscular booster with commercial vaccines.Zentralbl Veterinarmed B. 1999 Dec;46(10):713-22. doi: 10.1046/j.1439-0450.1999.00307.x. Zentralbl Veterinarmed B. 1999. PMID: 10676150
-
Evaluation of swinepox virus as a vaccine vector in pigs using an Aujeszky's disease (pseudorabies) virus gene insert coding for glycoproteins gp50 and gp63.Vet Rec. 1994 Jan 1;134(1):13-8. doi: 10.1136/vr.134.1.13. Vet Rec. 1994. PMID: 8128561
-
Marker vaccines, virus protein-specific antibody assays and the control of Aujeszky's disease.Vet Microbiol. 1990 Jun;23(1-4):85-101. doi: 10.1016/0378-1135(90)90139-m. Vet Microbiol. 1990. PMID: 2169682 Review.
-
Spread and control of Aujeszky's disease (AD).Comp Immunol Microbiol Infect Dis. 1991;14(2):165-73. doi: 10.1016/0147-9571(91)90129-2. Comp Immunol Microbiol Infect Dis. 1991. PMID: 1657510 Review.
Cited by
-
Glycoprotein E of pseudorabies virus and homologous proteins in other alphaherpesvirinae.Arch Virol. 1994;137(3-4):209-28. doi: 10.1007/BF01309470. Arch Virol. 1994. PMID: 7944945 Review.
-
Correlation between gI, gII, gIII, and gp 50 antibodies and virus excretion in vaccinated pigs infected with pseudorabies virus.Arch Virol. 1992;123(1-2):135-43. doi: 10.1007/BF01317144. Arch Virol. 1992. PMID: 1312820
-
Assessment of listing and categorisation of animal diseases within the framework of the Animal Health Law (Regulation (EU) No 2016/429): Aujeszky's disease.EFSA J. 2017 Jul 18;15(7):e04888. doi: 10.2903/j.efsa.2017.4888. eCollection 2017 Jul. EFSA J. 2017. PMID: 32625553 Free PMC article.
-
Limited protection conferred by a DNA vaccine against a lethal pseudorabies virus infection at day 5 postvaccination.Clin Vaccine Immunol. 2007 Apr;14(4):470-3. doi: 10.1128/CVI.00428-06. Epub 2007 Feb 14. Clin Vaccine Immunol. 2007. PMID: 17301217 Free PMC article.
-
Immune responses in pigs infected with porcine reproductive and respiratory syndrome virus (PRRSV).Vet Immunol Immunopathol. 1998 Feb 16;61(1):49-66. doi: 10.1016/s0165-2427(97)00134-7. Vet Immunol Immunopathol. 1998. PMID: 9613472 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical